Celularity Inc (CELU) concluded trading on Thursday at a closing price of $3.09, with 46.49 million shares of worth about $143.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.31% during that period and on November 07, 2024 the price saw a gain of about 113.10%. Currently the company’s common shares owned by public are about 19.38M shares, out of which, 10.71M shares are available for trading.
Stock saw a price change of 123.91% in past 5 days and over the past one month there was a price change of 26.64%. Year-to-date (YTD), CELU shares are showing a performance of 24.90% which increased to 35.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $7.97 during that period. The average intraday trading volume for Celularity Inc shares is 24.78K. The stock is currently trading 47.09% above its 20-day simple moving average (SMA20), while that difference is up 23.09% for SMA50 and it goes to -9.04% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Celularity Inc (NASDAQ: CELU) currently have 19.38M outstanding shares and institutions hold larger chunk of about 11.30% of that.
The stock has a current market capitalization of $67.94M and its 3Y-monthly beta is at 0.52. It has posted earnings per share of -$8.23 in the same period. It has Quick Ratio of 0.29 while making debt-to-equity ratio of 2.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CELU, volatility over the week remained 59.86% while standing at 25.61% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on January 30, 2023 offering an Underweight rating for the stock and assigned a target price range of between $5 and $1 to it. On June 22, 2022, H.C. Wainwright Initiated their recommendations, while on April 06, 2022, Truist Downgrade their ratings for the stock with a price target of $10. Stock get an Outperform rating from Oppenheimer on January 28, 2022.
